SFG
ABBV icon

Sather Financial Group’s AbbVie ABBV Stock Holding History

Sather Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$791K Buy
3,143
+42
+1% +$9.04K 0.05% 51
2026
Q1 		$674K Sell
3,101
-48
-2% -$10.6K 0.04% 55
2025
Q4 		$720K Buy
3,149
+55
+2% +$12.5K 0.04% 53
2025
Q3 		$716K Buy
3,094
+332
+12% +$67.6K 0.04% 52
2025
Q2 		$513K Buy
+2,762
New +$513K 0.03% 65
2024
Q2 		– Sell
-2,769
Closed -$504K – 84
2024
Q1 		$504K Sell
2,769
-56,790
-95% -$9.79M 0.04% 57
2023
Q4 		$9.23M Buy
59,559
+156
+0.3% +$22.7K 0.68% 29
2023
Q3 		$8.85M Buy
59,403
+613
+1% +$90K 0.74% 29
2023
Q2 		$7.92M Hold
58,790
– – 0.63% 33
2023
Q1 		$9.37M Hold
58,790
– – 0.81% 31
2022
Q4 		$9.5M Buy
58,790
+56,777
+2,821% +$8.71M 0.78% 35
2022
Q3 		$270K Buy
2,013
+13
+0.7% +$1.86K 0.03% 66
2022
Q2 		$306K Hold
2,000
– – 0.03% 66
2022
Q1 		$324K Buy
+2,000
New +$291K 0.03% 70
2020
Q1 		– Sell
-3,481
Closed -$308K – 61
2019
Q4 		$308K Buy
3,481
+381
+12% +$31.6K 0.05% 63
2019
Q3 		$234K Hold
3,100
– – 0.04% 52
2019
Q2 		$225K Hold
3,100
– – 0.04% 52
2019
Q1 		$249K Hold
3,100
– – 0.05% 49
2018
Q4 		$285K Hold
3,100
– – 0.06% 52
2018
Q3 		$293K Sell
3,100
-3,000
-49% -$284K 0.06% 51
2018
Q2 		$565K Buy
6,100
+100
+2% +$9.77K 0.13% 50
2018
Q1 		$568K Hold
6,000
– – 0.13% 49
2017
Q4 		$580K Hold
6,000
– – 0.14% 44
2017
Q3 		$533K Hold
6,000
– – 0.15% 45
2017
Q2 		$435K Buy
+6,000
New +$403K 0.13% 48

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sather Financial Group's ABBV Position: Q2 2026 in Review

Sather Financial Group increased its AbbVie (ABBV) stake by 1.4% in Q2 2026, buying an estimated $9.04K and bringing the position to 3,143 shares worth $791K. The position accounts for 0.05% of the portfolio, ranked #51.

Sather Financial Group first reported a position in ABBV in Q2 2017 and has held it in 25 quarters since. The position peaked at $9.5M in Q4 2022. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Sather Financial Group held 3,143 shares of AbbVie worth $791K as of Q2 2026.
  • Sather Financial Group bought 42 AbbVie shares in Q2 2026, an estimated $9.04K.
  • AbbVie made up 0.05% of Sather Financial Group's portfolio in Q2 2026, its #51 holding.
  • Sather Financial Group first reported a position in AbbVie in Q2 2017 and has held it in 25 quarters since.
  • Sather Financial Group's AbbVie position peaked at $9.5M in Q4 2022.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sather Financial Group's 13F filing for Q2 2026, filed 30 Jul 2026.